Home
About Us
About ReNeuron
Board of Directors
Senior Management
Advisory Board
Working at ReNeuron
Patents
Products
Our Products & Technologies
CTX cells for Stroke Disability
hRPCs for Retinal Disease
CTX-derived Exosomes
ReNcell Products
Publications
Clinical Trials
Clinical Trials
Phase I clinical trial in stroke disability (PISCES)
Phase IIa clinical trial in stroke disability (PISCES-II)
Phase IIb Clinical trial in stroke disability (PISCES III)
Observational study in stroke
Phase I/IIa clinical trial in retinitis pigmentosa
News
News Centre
News
Events
Media Coverage
Investors
Investor Centre
Corporate Governance
Share Price Information
Major Shareholdings
Advisors
Analyst Research
Financial Reports
General Meeting
Webcasts and Presentations
Financial Calendar
Email alerts
RNS Notifications
Documents and Circulars
AIM Rule 26
Declarations
Contact
Contact Us
Home
About Us
About ReNeuron
Board of Directors
Senior Management
Advisory Board
Working at ReNeuron
Patents
Products
Our Products & Technologies
CTX cells for Stroke Disability
hRPCs for Retinal Disease
CTX-derived Exosomes
ReNcell Products
Publications
Clinical Trials
Clinical Trials
Phase I clinical trial in stroke disability (PISCES)
Phase IIa clinical trial in stroke disability (PISCES-II)
Phase IIb Clinical trial in stroke disability (PISCES III)
Observational study in stroke
Phase I/IIa clinical trial in retinitis pigmentosa
News
News Centre
News
Events
Media Coverage
Investors
Investor Centre
Corporate Governance
Share Price Information
Major Shareholdings
Advisors
Analyst Research
Financial Reports
General Meeting
Webcasts and Presentations
Financial Calendar
Email alerts
RNS Notifications
Documents and Circulars
AIM Rule 26
Declarations
Contact
Contact Us
Email alerts
Section: Investors
The 100 to 1 share consolidation has taken effect
General Meeting
Email alerts
Investor Centre
Corporate Governance
Share Price Information
Major Shareholdings
Advisors
Analyst Research
Webcasts and Presentations
Financial Reports
Financial Calendar
RNS Notifications
Documents and Circulars
AIM Rule 26
Declarations